中慧生物公开认购超4000倍,能否复刻首日暴涨十倍的神话?

臻研厂
Aug 08

疫苗企业中慧生物-B于8月6日中午12时正式截止认购。据市场消息,中慧生物的公开发售部分录得约4000倍超额认购,认购金额超过2100亿港元,超越今年5月上市的沪上阿姨(超购约3616倍),成为2025年迄今为止的超购王第三位,仅次于布鲁可(超购5999倍)和蜜雪集团(超购5257倍)。公司简介中慧生物科技股份有限公司是一家专注于人用疫苗研发、生产和销售的内地企业,产品涵盖狂犬病疫苗、乙肝疫苗等,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10